Cargando…

Classic and New Animal Models of Parkinson's Disease

Neurological disorders can be modeled in animals so as to recreate specific pathogenic events and behavioral outcomes. Parkinson's Disease (PD) is the second most common neurodegenerative disease of an aging population, and although there have been several significant findings about the PD dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blesa, Javier, Phani, Sudarshan, Jackson-Lewis, Vernice, Przedborski, Serge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321500/ https://www.ncbi.nlm.nih.gov/pubmed/22536024 http://dx.doi.org/10.1155/2012/845618

Ejemplares similares

Parkinson’s disease: animal models and dopaminergic cell vulnerability
por: Blesa, Javier, et al.
Publicado: (2014)

Neuroprotection and neuroregeneration triggered through the FUS-induced opening of the blood-brain barrier in a Parkinson’s mouse model
por: Konofagou, Elisa, et al.
Publicado: (2015)

Oxidative stress and Parkinson’s disease
por: Blesa, Javier, et al.
Publicado: (2015)

Focused ultrasound enhanced intranasal delivery of brain derived neurotrophic factor produces neurorestorative effects in a Parkinson’s disease mouse model
por: Ji, Robin, et al.
Publicado: (2019)

The Role of the Innate Immune System in ALS
por: Phani, Sudarshan, et al.
Publicado: (2012)

Identification of Neurodegenerative Factors Using Translatome-Regulatory Network Analysis
por: Brichta, Lars, et al.
Publicado: (2015)

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
por: Banerjee, Rebecca, et al.
Publicado: (2008)

Animal Model for Prodromal Parkinson’s Disease
por: Taguchi, Tomoyuki, et al.
Publicado: (2020)

Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022)

Lipopolysaccharide Animal Models for Parkinson's Disease
por: Liu, Mei, et al.
Publicado: (2011)

Limitations of Animal Models of Parkinson's Disease
por: Potashkin, J. A., et al.
Publicado: (2010)

Editorial: Parkinson's disease: cell vulnerability and disease progression
por: Blesa, Javier, et al.
Publicado: (2015)

Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease
por: Lim, L, et al.
Publicado: (2012)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Animal Models for Parkinson’s Disease Research: Trends in the 2000s
por: Kin, Kyohei, et al.
Publicado: (2019)

Parkinson’s Disease: Exploring Different Animal Model Systems
por: Khan, Engila, et al.
Publicado: (2023)

Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson’s disease
por: Irmady, Krithi, et al.
Publicado: (2023)

Therapeutic Effects of Hydrogen in Animal Models of Parkinson's Disease
por: Fujita, Kyota, et al.
Publicado: (2011)

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2010)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Changes in thalamic dopamine innervation in a progressive Parkinson's disease model in monkeys
por: Monje, Mariana H.G., et al.
Publicado: (2019)

Animal Models of Parkinson's Disease
por: Imai, Yuzuru, et al.
Publicado: (2011)

Animal Model for Lower Urinary Tract Dysfunction in Parkinson’s Disease
por: Kitta, Takeya, et al.
Publicado: (2020)

Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
por: Prasad, E. Maruthi, et al.
Publicado: (2020)

Photobiomodulation for Parkinson’s Disease in Animal Models: A Systematic Review
por: Salehpour, Farzad, et al.
Publicado: (2020)

Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models
por: Muksuris, Katherine, et al.
Publicado: (2023)

Animal Models of Autosomal Recessive Parkinsonism
por: Bastioli, Guendalina, et al.
Publicado: (2021)

Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease
por: Deng, Isaac, et al.
Publicado: (2020)

Animal Models of Parkinson's Disease 2012
por: Imai, Yuzuru, et al.
Publicado: (2012)

Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment
por: Zeng, Xian-Si, et al.
Publicado: (2018)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
por: Buhidma, Yazead, et al.
Publicado: (2020)

Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
por: Dovonou, Axelle, et al.
Publicado: (2023)

The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study
por: Feeney, Megan P., et al.
Publicado: (2021)

New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics
por: Ortega Moreno, Lorena, et al.
Publicado: (2023)

Neurochemical changes in animal models of Parkinson’s disease
por: Baranyi, Mária, et al.
Publicado: (2013)

Impact of aging on animal models of Parkinson's disease
por: Klæstrup, Ida Hyllen, et al.
Publicado: (2022)

Modeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care
por: Yun, Jun-Won, et al.
Publicado: (2015)

Classical and Emerging Regulatory Mechanisms of Cytokinesis in Animal Cells
por: Verma, Vikash, et al.
Publicado: (2019)

Neurogenesis in Neurotoxin-induced Animal Models for Parkinson’s Disease—A Review of the Current Status
por: He, Xi Jun, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0it9hvaucs8f6jnn56tkiertn2